A detailed history of Axa S.A. transactions in Verona Pharma PLC stock. As of the latest transaction made, Axa S.A. holds 278,025 shares of VRNA stock, worth $12.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
278,025
Holding current value
$12.5 Million
% of portfolio
0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.46 - $30.16 $4.3 Million - $8.39 Million
278,025 New
278,025 $8 Million
Q1 2024

May 15, 2024

BUY
$15.3 - $20.24 $1,208 - $1,598
79 Added 0.03%
277,784 $4.47 Million
Q4 2023

Jul 16, 2024

SELL
$11.94 - $20.47 $943 - $1,617
-79 Reduced 0.03%
277,705 $5.52 Million
Q4 2023

Feb 14, 2024

SELL
$11.94 - $20.47 $80,236 - $137,558
-6,720 Reduced 2.36%
277,705 $5.52 Million
Q3 2023

Nov 14, 2023

BUY
$16.3 - $22.09 $483,555 - $655,321
29,666 Added 11.64%
284,425 $4.64 Million
Q2 2023

Aug 14, 2023

BUY
$19.41 - $23.43 $4.94 Million - $5.97 Million
254,759 New
254,759 $5.39 Million

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $2.75B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.